NCT06748261Not yet recruiting
AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA
Artificial Intelligence-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary Computer Tomography Angiography
Source: ClinicalTrials.gov · Last updated 27 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational and diagnostic study is to develop and validate an artificial intelligence assisted approach for coronary computer tomography angiography-(CCTA)-based screening and diagnosis of cardiomyopathies in patients with suspected coronary artery diseases. This study aims to develop a computerized CCTA interpretation using artificial intelligence for multi-label classification task to assist cardiomyopathy diagnosis in the clinical workflow.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 17 Dec 2024
- Start date
- 30 Dec 2024
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Shanghai Zhongshan Hospital
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT06748261
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 30 Dec 2024 to the primary completion date, 30 Jun 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Cardiomyopathy cohort:
- Inclusion Criteria:
- A clinical diagnosis of cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, cardiac amyloidosis, myocarditis, arrhythmogenic right ventricular cardiomyopathy, and coronary artery disease/ischemic heart disease.
- At least one CCTA before surgery or implantable device treatment.
- Exclusion Criteria:
- No recorded diagnosis of cardiomyopathy or undetermined type of cardiomyopathy.
- A clinical diagnosis of secondary cardiac abnormalities due to other organic or systemic diseases.
- Surgery or implantable device treatment before CCTA examination.
- Control cohort:
- Inclusion Criteria: participants with at least one CCTA examination.
- Exclusion Criteria: clinical diagnosis of cardiovascular diseases (including cardiomyopathy, history of myocardial infarction, history of cardiac surgery, stent implantation, ICD implantation and so on) or secondary cardiac abnormalities due to systemic diseases.
Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.